Been here since 6c... and have never sold a single share. We...

Been here since 6c... and have never sold a single share. We have been in the right direction and I think that within the next quarter or two they will be able to generate significant commercial deals for the diagnostics and hopefully other things. Market is basing its current valuation of $150m on that. I still think it’s way too low given the potential for the next few years. Looking at WBT for example, mcap is $320m and these guys are nowhere near a commercialised product let alone revenue. The agreement was announced almost a year ago... so I would have thought the market already factored in the fact that it’s not really progressing. in any case I don’t see much value in PPE deals that was so much 2020 (and Dtz perhaps has few more hundred $$$ revenue that should come in from that). The biggest growth engine in my view will be the testing kits and I hope some of the other projects (oil, cigarettes etc)